PharmaCyte Biotech, Inc. Human Resources Contracts & Agreements
12 Contracts & Agreements
- Bonus & Incentive Agreements (1 contract)
- Compensation Agreements (4)
- Consulting Agreements (6)
- Employment Agreements (1)
- Separation, Consulting and Release Agreement, dated October 6, 2022, by and between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner (Filed With SEC on October 7, 2022)
- PharmaCyte Biotech, Inc. 2021 Equity Incentive Plan (Filed With SEC on July 28, 2022)
- Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Carlos A. Trujillo and the Company (Filed With SEC on July 28, 2022)
- Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Kenneth L. Waggoner and the Company (Filed With SEC on July 28, 2022)
- Amendment No. 3, dated as of October 14, 2020, to Executive Compensation Agreement between Gerald W. Crabtree and the Company (Filed With SEC on October 16, 2020)
- AMENDMENTNo. 2 TO executive Compensation AGREEMENT (Filed With SEC on March 13, 2017)
- Consulting Agreement (Filed With SEC on October 3, 2014)
- Consulting Agreement (Filed With SEC on October 3, 2014)
- Consulting Agreement (Filed With SEC on October 3, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2014)
- MASTER CONSULTANCY AGREEMENT Between Nuvilex, Inc. And BB Biotech Consulting GmbH (Filed With SEC on August 4, 2014)
- CONSULTING AGREEMENT (Filed With SEC on August 4, 2014)
